Dementia: Definition, Types, and Causes

Dementia is an acquired syndrome of progressive cognitive decline interfering with independence in daily activities. It is not a single disease but a clinical manifestation of various underlying neuropathologies.

Core Diagnostic Criteria (DSM-5: Major Neurocognitive Disorder)

  • Significant cognitive decline from baseline in ≥1 domain: complex attention, executive function, learning/memory, language, perceptual-motor, social cognition.
  • Interferes with independence (IADLs → ADLs).
  • Not due to delirium or primary psychiatric disorder.

Major Etiologies

Other Causes

  • Parkinson's disease dementia (PDD)
  • Normal pressure hydrocephalus (NPH) — potentially reversible
  • Chronic traumatic encephalopathy (CTE)
  • Prion disease (CJD) — rapidly progressive
  • HIV-associated neurocognitive disorder (HAND)
  • Metabolic/toxic: B12 deficiency, thyroid, alcohol, heavy metals
  • Medication effects (anticholinergics, benzos, opioids)

Reversible "Pseudodementia" Considerations

  • Depression (cognitive slowing, apathy)
  • Medication toxicity
  • Endocrine (hypothyroid, hypercalcemia)
  • Infection (neurosyphilis, HIV)
  • Structural (NPH, subdural hematoma)

Evaluation

  • History (informant essential), cognitive screen (MoCA, MMSE), functional assessment.
  • Labs: CBC, CMP, TSH, B12, folate, RPR, HIV.
  • Neuroimaging: MRI (atrophy pattern, vascular burden, NPH) or CT.
  • CSF (Aβ42, p-tau) or amyloid PET if atypical/early-onset.

Management

  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) — AD, LBD, PDD, VaD.
  • Memantine (NMDA antagonist) — moderate-severe AD.
  • Non-pharmacologic: cognitive stimulation, exercise, social engagement, caregiver support.
  • Treat comorbidities, optimize sensory input, advance care planning.

Early diagnosis enables planning, clinical trial access, and symptomatic treatment.

Brain & Nervous System - Related Articles

Health Sciences © https://www.222health.com

TypeProportionKey PathologyTypical Features
Alzheimer's disease (AD)60–80%Amyloid plaques, neurofibrillary tangles (tau)Amnestic onset, gradual progression, parietal-temporal atrophy
Vascular dementia (VaD)10–20%Cerebrovascular disease (infarcts, small vessel)Stepwise decline, executive prominence, gait/urinary signs
Lewy body dementia (LBD)5–15%α-synuclein (Lewy bodies) in cortex/brainstemFluctuating cognition, visual hallucinations, parkinsonism, RBD
Frontotemporal dementia (FTD)5–10%TDP-43, tau, FUS; frontal/temporal atrophyBehavioral (bvFTD) or language (PPA) variants; early age (45–65)
Mixed dementiaCommon (>50% >80y)AD + VaD, AD + LBD, etc.Combined features